CHANNAIAH SRIKANTH MYSORE
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology SALISBURY, MD NPI 1881900652
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology MD ABBVIE INC. All categories
General Payments — all program years on this page
$5,235.11
- Category: General Payments
- Program years: PY2019–2023
- Record count: 341
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $884.81 across 50 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $884.81 | 50 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $165.02 | 13 |
| SK Life Science, Inc. | $90.23 | 3 |
| UCB, Inc. | $86.03 | 4 |
| EMD Serono, Inc. | $66.72 | 4 |
| Corium, Inc. | $55.45 | 3 |
| ARGENX US, INC. | $43.43 | 2 |
| EISAI INC. | $38.50 | 2 |
| Amneal Pharmaceuticals LLC | $33.03 | 2 |
| JAZZ PHARMACEUTICALS INC. | $31.24 | 1 |
| Acorda Therapeutics, Inc | $30.47 | 2 |
| Lilly USA, LLC | $29.35 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $22.40 | 1 |
| Merz Pharmaceuticals, LLC | $21.67 | 1 |
| Ipsen Biopharmaceuticals, Inc | $21.22 | 1 |
| MDD US Operations, LLC | $19.88 | 1 |
| Otsuka America Pharmaceutical, Inc. | $19.46 | 1 |
| Biogen, Inc. | $18.81 | 1 |
| IMPEL PHARMACEUTICALS INC. | $17.88 | 1 |
| Cala Health, Inc. | $17.69 | 1 |
| Sumitomo Pharma America, Inc. | $14.98 | 1 |
| Neurocrine BioSciences, Inc. | $14.40 | 1 |
| Teva Pharmaceuticals USA, Inc. | $13.91 | 1 |
| Alexion Pharmaceuticals, Inc. | $13.04 | 1 |
By program year
Records — PY2023 (50)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.